Transplanted friendship
Amelia Brown was a homecoming queen in the prime of her life, but her liver was failing from a mysterious illness. UK HealthCare solved the mystery, found her a new liver and made friends for life.
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The Markey Cancer Center
With its friendly feel and attentive service, it feels almost like a comfortable neighborhood bar. And when myeloma patient Kelly Colson visits, he sees a glass that's more than half-full.
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ALS can't silence her
While Mary Lou Smith has lost use of her vocal cords, she hasn't lost hope. In an article she pens herself, she talks about how Dr. Edward Kasarskis and his team put her at ease. UK HealthCare is much more than our advanced medical technology. It is the physicians, nurses and technicians who use that technology correctly and effectively. Beyond our advanced capabilities, UK HealthCare is everyone who makes a difference to our patients by connecting with them on a personal level, easing their fears and offering comfort as they face conditions that are often life-threatening and certainly life-changing.
Making a Difference will introduce you to colleagues who go the extra mile to diagnose and treat illness while providing emotional support in even the smallest ways-recommending treatment options, providing health information, offering words of encouragement or simply remembering a name. All of these elements are meaningful.
As you read Making a Difference, you'll see we are focusing on members of the UK HealthCare family who are making a difference to our patients, many of whom are overcoming amazing odds thanks to our comprehensive and compassionate care. They make UK HealthCare an extraordinary organization, and it is a story worth sharing. A mysterious liver disease was making her sleepy and lethargic. Her skin was yellow from jaundice. She passed several gallstones. An inability to absorb calcium caused her to break her hip-and she didn't even know it.
Her digestive system disrupted, she sometimes vomited between classes on the UK campus.
Worst of all was the itching-the result of too much bile in her blood. "It makes me itch now just thinking about it," the Tompkinsville native said recently.
Brown was 19 when she found out she had liver disease, just before Long live the Queen starting her freshman year at UK in the fall of 2000. But doctors who initially examined her in Nashville were unable to diagnose the specific malady. When another flare-up struck that Christmas, they sent her to a prominent organ transplant center in Pennsylvania, where her name was put on a waiting list for a new liver.
Even with her condition deteriorating, Brown pressed on with her education. She not only continued taking classes, she became vice president of Delta Gamma sorority, a senator-at-large in student government and a UK Ambassador. She was crowned the UK Football Homecoming Queen in 2003, volunteered for Kentucky Organ Donor Affiliates and led UK in the Gift of Life Challenge against the University of Louisville to sign up organ donors. She graduated in December 2003-a semester early! Through it all, she waited patiently for a new liver. And waited. And waited. More than three years passed, and still she heard nothing from the transplant center in Pennsylvania.
'I just loved the people' at UK "They didn't really stay in close contact with me," Brown said. "So finally, since I had done the Gift of Life Challenge, UK HealthCare called me and said, 'Why don't you come and be evaluated for our list?' So I went and I just loved the people. I felt comfortable with them. They assigned me a nurse coordinator and she kept a close eye on me from beginning to end." UK HealthCare not only made the diagnosis that had eluded doctors in Nashville-primary sclerosing cholangitis, in which a person's immune system mistakenly attacks its own liver-it also found her the new liver she so desperately needed. Brown remembers the exact moment she got the call: 12:32 a.m. on Sunday, April 3, 2005. A family had agreed to donate a liver. The next day UK's skilled transplant team implanted that liver in Brown's abdomen and, after another surgery to repair her hip fracture, her long but welcome recovery was under way.
More than a year later, Brown still gets emotional about the family's gift. "I was at the end of my rope," she said. "I was getting sicker and sicker every minute. It's a blessing to know that the donor's family, through their pain, found a reason to let me live." Nurse Dana Grantz: "We become very close....This is life and death."
Brown believes she would not be here today were it not for UK HealthCare-and she's grateful to a number of people, including Dana Grantz, the nurse coordinator assigned to her. "She has a great sense of humor, and you need that when you're going through this," Brown said. "I was going through a lot physically, but you go through a lot mentally too, waiting on a list like that. It was comforting having people like Dana to depend on."
Each of the four nurse coordinators in Grantz's unit monitors about 200 patients-from the time they come "I was at the end of my rope. It's a blessing to know that the donor's family, through their pain, found a reason to let me live."
Liver transplant recipient Amelia Brown with some of the cadre of staff necessary to support a transplant patient. From l. to r., Gail Starnes, RN; Liz Corio, MSW; Vicky Turner, ARNP; Brown; Lynne Polly, RN; Dana Grantz, RN, transplant nurse coordinator; Jennifer Watkins, RN; and Janet Brown, phlebotomist.
• More than 600 people in Kentucky are registered on the United Network for Organ Sharing waiting list for donated organs.
• Every year, an estimated 3,000 people in the U.S. die while waiting for an organ transplant.
• Transplantable organs include the kidney, heart, liver, lung, pancreas and small bowel. Transplantable tissues include bone, cartilage, skin, corneas, heart valves, saphenous veins, tendons and ligaments.
• Acceptable donors range from newborn to senior citizens.
• Organs that can be used from a living donor include kidney, liver, intestine, pancreas and lung.
• In 2005, approximately 28,000 successful organ transplants were performed. It is estimated twice as many could have been performed if more people donated organs.
• By law, donation is the right of every American age 18 and older. Hospitals are obligated by law to identify potential donors and to inform families of their right to donate.*
• Individuals may indicate their wish to be a donor by signing a driver's license or a donor card. However, next-of-kin are still asked to give permission to donate. Therefore, individuals should inform their loved ones about their decision.
• All efforts are made to save a person's life regardless of whether he or she has signed a donor card. Doctors involved in treating a patient cannot be involved in donation or transplantation.
• There is no extra expense for the family donating organs or tissues.
• The donor's body is not disfigured by organ or tissue removal.
• All major religions approve of organ and tissue donation.
Facts excerpted from Kentucky Organ Donor Affiliates, www.kyorgandonor.org.
*UNOS (United Network for Organ Sharing), www.unos.org.
into the system through follow-up visits for the rest of their lives. The coordinators manage the patient's blood work, keep track of his or her overall health and serve as the link between patient and surgeon. "Once we're assigned a patient," Grantz said, "we communicate with them constantly. We're scheduling tests, obtaining test results, explaining results and discussing infections, medications and questions regarding their illness. We become very close to the patients and their families. This is life and death.
"The relationships we build last a lifetime," she added. "From the first time they enter our clinic, to the testing that's done in order to be placed on a waiting list, waiting for the perfect match and then following them after transplant, we do not stop. We follow them forever."
"The people at UK HealthCare really keep in touch with you," Brown said. "Gail Starnes, a nurse on my floor, still calls me to make sure I'm okay. That makes me feel pretty good."
Dr. Dinesh Ranjan, director of the UK liver and pancreas program and the lead surgeon in Brown's case, said Amelia came to the right place for outstanding care. "We have an excellent team that follows patients very closely," Dr. Ranjan said. "You saw the result of that in Amelia, who started out with another center and was not doing well. She was wise enough to transfer her care here and subsequently did very well." Amelia Brown: "I've never felt this good in my life."
Brown, who now works for UK as a Fayette County cooperative extension agent, will have to take anti-rejection medication for the rest of her life. But her health now versus before the surgery "is like night and day," she said. "I've never felt this good in my life. I didn't even know what good felt like." She is also working toward a doctorate in family studies, which will allow her to research and teach in the area of family health, a career choice inspired in part by her experience. Dr. Dinesh Ranjan, director of the UK liver and pancreas program, has taken part in more than 500 transplants during his career, including more than 300 at UK. He believes the program must balance high tech with high touch.
Asked how UK was able to diagnose Brown's disease when others could not, Dr. Ranjan said, "It was simply being familiar with patients who have advanced liver disease and pursuing it with the right diagnostic tests.
"She was not getting the followup patients like Amelia need. This was probably due to the distance, and the other program may not have been able to provide more personal attention to her as they may have too many patients. We are very involved in our patients on the waiting list as well as post-transplant. We are appropriately aggressive when needed, such as in using livers we think may suit our patients while others may have turned it down. The end result is a shorter waiting time."
Dr. Ranjan explains the more aggressive management includes a double team approach that improves the quality of the grafts, as well as aggressive intra-and post-operative management to improve outcomes with these grafts. High touch extends to the patient's referring physician and family doctor. Close contact is maintained before and after the operation because the referring physician is considered part of the transplant team. "We pride ourselves on the level of communication we have with them," said Dr. Ranjan.
For three months after transplant, the program's physicians serve as the patient's primary doctors to monitor every health issue the patient might encounter. But if they are doing well after the first three months, transplant patients are referred back to their own doctors. "It's not cutting the cord, just lengthening it," said Dr. Ranjan.
That cord will always be there for Amelia Brown.
"We will still be checking her blood work and lab tests every month or every other month, as it may be, and the test results will be faxed to us," he said. "Amelia and her referring physician will know we are always available, 24/7. So if there are any issues, we'll be called and we'll be there for her." Until UK started running television spots featuring their doctors, I thought the hospital was just for people who couldn't pay. I have talked to others who thought the same way. One of my friends has a son who suffers from seizures and she loves the pediatric department. My sister-in-law's mother had a hardto-perform surgery here and she lives in Nevada. She's flying back here now for follow-ups.
UK
I am so happy they are letting everyone know that there are so many good people working at UK. I certainly couldn't be more impressed with the level of personal care I've received. In fact, some days, I just want to scream with joy.
Mary Lou Smith (far left) with Nadine Deehan, LPN, whose hug after Smith received her diagnosis meant a lot. Deehan lost her own father to ALS and is not afraid to show compassion. Said Deehan, "If I didn't treat my patient the way I would want to be treated, why would I be doing this?"
In looking for a second opinion, Mary Lou Smith was won over by UK neurologist Edward Kasarskis' smile and the fact that he made her feel comfortable.
*Mary Lou has since retired from her job and stays busy working with the local ALS chapter. In May, she and her family represented Kentucky at National Advocacy Day in Washington, D.C.
For amyotrophic lateral sclerosis (ALS) patients, the best way to extend their life may not lie in new miracle drugs being developed, but in peanut butter, slices of cheese and protein shakes.
The importance of nutrition is one focus of a new national study UK HealthCare is leading entitled "Early Treatment of ALS with Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV)." In addition to nutrition, part of the study deals with medical devices that support a patient's respiratory functions.
A weighty matter
According to Dr. Edward Kasarskis, a UK neurologist and the study's primary investigator, changes in a patient's physical activity, breathing status and body composition can affect how many calories he or she burns each day as the disease takes its toll.
"We often see patients who don't keep up with their nutrition, and they lose excessive amounts of weight… really huge amounts of weight in a very short period of time," said Dr. Kasarskis. "It's likely this accelerates the course of the disease."
Research bionutritionist Karen Kitzman, RD, also involved in the study, added, "If we can keep these patients' nutritional status up and decide early enough whether they need supplementary feeding tubes, then maybe we can prolong their healthy status."
Kitzman noted that by the time a patient has to have a supplementary feeding tube to live, it is often too late-they are malnourished. Their body's energy stores are depleted and they begin to break down muscle tissue for energy. These patients may not heal well or even be able to tolerate the food going into the feeding tube.
"However, if we add a PEG (percutaneous endoscopic gastrostomy) to a healthy patient who has decreasing calorie intake, that early start can give them the extra calories needed to maintain their nutrition level through some other ups and downs," Kitzman said.
Increasing the calories
For ALS patients who can swallow, Kitzman often suggests high-calorie snacks such as peanut butter or cheese-foods with higher protein and fat content in them. She recommends meal supplements such as Boost, Ensure and Carnation Instant Breakfast because they taste good and can be thickened with ice cream or commerical thickener, which makes them easier to swallow. She encourages use of a liquid, flavorless calorie booster that can be added to drinks and foods. This product can be added to almost any food without altering taste.
"The people we work with have some of the best attitudes," said Stephen Wells, a clinical research coordinator on the project. "We never run into a patient who doesn't want to be here. They all realize they may never benefit from the information they're giving us, but the people who come after them might."
Untold promise for the future
Dr. Kasarskis predicts the third phase of the research, which ends late next year, holds untold promise for the future. "The actual importance of this approach goes beyond individual patients because all clinical trials of new medications are being done without standardizing nutrition and respiratory assistance. Nutrition and support of respiratory function are probably going to be more important in extending survival than any drugs themselves." "We never run into a patient who doesn't want to be here. They all realize they may never benefit from the information they're giving us, but the people who come after them might." 
Going to Bat Against ALS with Nutrition
Stephen Wells and Karen Kitzman, RD, LD, investigate whether additional nutritional and respiratory support will prolong survival for ALS patients. No, what Colson has that spreads so easily is a good thing. It's called optimism. Symptoms include frequent smiling, living life to its fullest, tackling new challenges and making light of his situation. "It's just cancer," and no matter how he feels, he enjoys catching people off-guard by telling them he feels "marvelous!" Colson may grossly understate the obvious in an attempt at humor, but he is completely aware multiple myeloma
Kelly Colson Photo
is an incurable blood disorder that is to be taken very seriously.
"We've all got expiration dates," said the 46-year-old Lexington resident. "Some are just earlier than others." The way Colson sees it, being diagnosed with an incurable cancer is no reason to turn bitter and mean to friends and family who are there to help and support you.
That attitude may literally prolong his life. His primary physician, Dr. Dianna S. Howard, a UK hematologist, said every patient has a different coping strategy when faced with a life-threatening illness. While some take a defeatist view, "others say, 'I'm going to live my life, make the best of it and go forward.' Kelly epitomizes that," Dr. Howard said. "When people do that, they keep going a lot longer."
Charlotte English, a nursing care technician in the Markey Cancer Center since 1999, has drawn Colson's blood and checked his vital signs dozens of times. That means she's had a lot of time for small talk. "The man never has a bad day," she said. "He comes in here, and you might expect him to be down because he's in a cancer center, but he always asks how I'm doing. On my birthday he called to wish me a happy birthday and he and his wife got me a gift certificate to Rafferty's."
A New Outlook 
A disturbing diagnosis
Colson's life changed one day in late October 2003, just after he and his wife Teresa returned from a trip to Mexico.
He was mowing the grass when he felt a sharp pain in his right shoulder. "I don't know if you've ever had a broken bone, but it just snapped," Colson recalled. "I was delirious with pain."
Charlotte English has a 62-mile commute to her job as a nursing care technician for Markey Cancer Center. Each workday this single mother of five makes a 124-mile roundtrip from her home in Flemingsburg to Lexington and back.
"I love my job, I love the patients and I love the people I work with," she said. English considered cutting back to three days in order to reduce driving time, but when she realized she wouldn't get to see the patients she normally sees, she changed her mind.
"So now, they say, 'Charlotte, I thought you were leaving,' and I'll say, 'Look, I tried to leave you, but I can't!'" English now works four days a week, Charlotte English: "I Never Leave This Place Feeling Depressed." "I love my job, I love the patients and I love the people I work with." -Charlotte English, Nursing Care Technician four 10-hour shifts.
"I'm one of those people who just go high-speed constantly," she said. "If we have a busy day, I don't stop." A self-described "people person," English gets to know every one of the 10 to 30 patients she encounters each day, taking their vital signs, drawing blood and providing triage. And they get to know her in return.
Performing her job with pride since 1999, the year after her father died of cancer, she reflected, "You might think working in a cancer center has got to be depressing, but I never leave this place feeling depressed. The people you meet touch your heart one way or another."
Cancer patient Kelly Colson is feeling well enough to turn the tables on Jason Ritchey, a patient care associate in the Markey Cancer Center, and take him for a spin.
X-rays showed a fractured bone in his upper right arm. Worse, the X-rays also showed the cancer. A very aggressive tumor inside the bone had weakened Colson's right humerus, or upper arm bone, causing it to shatter.
Treatment would not be a simple proposition. There is no known cure for myeloma, which causes an overproduction of certain proteins in the bone marrow. Myeloma-usually called "multiple" because it shows up in several bones throughout the body-can be treated with surgical removal of tumors, but they may pop up somewhere else later. Radiation, corticosteroids, stem-cell transplants, chemotherapy and other medications are also effective in managing the disease-but major bone breaks such as Colson's complicate the situation.
The first order of business was to excise the tumor in Colson's shoulder and replace the joint with one made mostly of titanium. The surgery went well, but in the spring of 2004 he suffered near-fatal blood clots in his lungs, which caused him to be hospitalized for another 16 days. Follow up chemotherapy had to be delayed.
By the summer of that year, Colson was ready for another big procedure-a stem cell transplant. UK doctors extracted stem cells-the building blocks for all cells-from his bone marrow. They administered a very high dose of chemotherapy to attempt to eradicate myeloma cells and then returned the stem cells to his body to promote remission. Colson's condition has been stable since that time.
A new freedom
Trying to work a demanding job had become extremely difficult given his frequent health-related absences following treatments he received. Colson elected to quit work and focus on the treatment of his illness.
That downtime didn't last long. It was all the incentive he needed to build up a part-time consulting business in November 1999. In keeping with his sunny disposition, he named it Sunshine Services LLC. Ironically, the change has given him a new sense of freedom. "I wish I had done it 20 years ago," Colson said with a laugh. "Business is great."
Stable for over a year, Colson is realistic but hopeful about his shortand long-term prognosis. Colson said he enjoys good nutritious food. His condition is being managed with a variety of medications, including a blood thinner, a bone-strengthener and thalidomide-a once-notorious drug now undergoing a remarkable rehabilitation.
Another stem cell transplant for Colson is possible, although Dr. Howard is cautious because the procedure has serious side effects and is not always effective. Other options are possible as well. (See related story.)
Whatever the future holds, Colson has forged a strong bond with the supportive, nurturing staff of UK HealthCare. "Periodically, I take four or five pizzas into the clinic around lunchtime for the staff," he said. "Of course, if you take food to hungry people, they love you. The way I look at it, I'm investing in my future. If the doctors and staff are working hard to keep me alive, the least I can do is feed them occasionally." "Believe me, when you're really sick and the reality sets in that you are not going to live forever, you want to be with knowledgeable health care professionals who genuinely care about your well being and quality of life." Jason Ritchey's ever present smile is one of the first things a Markey cancer patient sees.
"When you're really sick and the reality sets in that you are not going to live forever, you want to be with...professionals who genuinely care about your well being and quality of life."
Thanks in part to novel research being conducted at UK, Dr. Dianna Howard believes the very best options for cancer patients are here.
The drug thalidomide is expanding the options available to multiple myeloma patients.
Kelly Colson has undergone one successful stem cell transplant to treat his multiple myeloma and another is possible down the road. If he does make that choice, UK HealthCare is the only center in the region where such a procedure is offered. While a second transplant is possible, the good news is the options for Colson and other multiple myeloma patients are expanding rapidly. Although the blood cell cancer is still described as incurable, researchers have been encouraged by several developments that are letting myeloma patients live longer, healthier lives.
The median survival for patients with multiple myeloma has more than doubled in the past decade. Newer treatment options have allowed patients who once died within two to three years to think of their condition as chronic. Additionally, newer drugs that target the biologic weaknesses of the myeloma are associated with fewer life-threatening and life-altering toxicities.
A drug Colson is taking, thalidomide, falls into this category. In the 1960s thalidomide attained possibly the worst reputation of any drug ever marketed. Pregnant women given this anti-nausea/sedative medication gave birth to babies with grossly underdeveloped arms and legs, as well as other defects. Later, however, resourceful researchers began investigating the possibility that a drug that hampered limb growth in fetuses would also block tumor growth.
"This is an area where there have been incredible advances," said Dr. Howard. "In the last five to 10 years there have been at least three new agents approved for use in multiple myeloma." As with other new anti-cancer drugs, these new agents zero in on the cancer while sparing healthy cells, she said.
With advances being made constantly, Dr. Howard believes UK HealthCare offers the best possible options for cancer patients like Colson. New drugs are usually available years earlier at an academic center than they are in other settings. As part of an academic institution, the Markey Cancer Center pairs clinical researchers with scientists to promote the translation of laboratory observations into clinical trials, which in turn provides a venue for clinical observations to raise new scientific questions and influence the direction of new research.
"We work with the College of Pharmacy in new drug development and novel therapeutics. That's something you're not going to find except in a cancer center and in an academic center," she said. Over the years, UK Chandler Hospital has continued to play an important role in her life. It was where she first entered the work world as a nurse in the early 1980s. It's where she now works in the UK HealthCare call center's pediatric triage service. It's where her husband works as a pharmacist. And it's where, over the last four decades, she has received treatment for cystic fibrosis (CF).
Long-term relationships
According to the National Institutes of Health, CF is the most common fatal genetic disease in the U.S. It causes the body to produce a thick, sticky mucus that clogs the lungs and leads to infection. It also prevents digestive enzymes produced in the pancreas from reaching the intestines where they are required to digest food.
There is no cure for CF and the present life expectancy for people affected by it is usually their mid-30s. McMahan has beaten the averages. She is 48 years old and going strong.
McMahan credits her longevity and quality of life in large part to the aggressive medical care provided by her UK physicians: Dr. Jamshed Kanga and Dr. Michael Anstead. "I've had the same physicians for over 23 years. I've joked with Dr. Kanga that I'm going to live to take care of him as an old man," she said.
Because she has a less severe form of CF and her obvious symptoms Since 1989 when the gene that causes cystic fibrosis (CF) was first discovered, the median lifespan for patients with the disease has increased by more than 10 years. And nearly half of that increase has come during just the last five years.
According to Dr. Michael Anstead, director of the adult CF Center, the median survival rate has jumped from 31.6 years in 2002 to 36.8 in 2004-up from just 26.5 years in 1989. (When McMahan was born, patients rarely made it to puberty, often succumbing to the disease as young children.)
He attributes the increase in his own patients' survival to three things: 1) a more uniform use of aerosolized antibiotics that fight the bacteria that invade the lungs of many patients; 2) use of antibiotics with special properties that inhibit the ability of the bacteria to produce toxins and are anti-inflammatory; and 3) an initiative undertaken by the Cystic Fibrosis Foundation to improve the quality of care for CF patients.
"One of the great developments in Kentucky is that we now do newborn screenings for cystic fibrosis," he said. Through the lobbying efforts of Drs. Anstead and Mabry, Anne's father, CF was included in the newborn screening tests implemented by SB 25 passed during the last Kentucky legislative session. This screening can identify 99 percent of babies born with CF. If those patients can be identified and monitored through each lung infection, the bacteria might be prevented from growing in their lungs. Once it takes hold, it is extremely difficult to dislodge.
"In Denmark, only 20 percent of teenagers affected with CF are infected with this bacteria," he said. "In the U.S., 70 percent are infected with it. Denmark's median lifespan is about 45 years. So we're starting to adopt some of the principles they've learned over time. It will help the CF patients who are children today." Anne works at UK HealthCare, where she also receives treatment for her cystic fibrosis.
Pulmonologists Michael Anstead, MD, and Jamshed Kanga, MD, collaborate closely to ensure a smooth transition from pediatric to adult care for CF patients.
did not begin until age 8, it wasn't until she was in college (where she was finally diagnosed) that she sought treatment from Dr. Kanga, a pediatric pulmonologist. When Dr. Anstead, who is certified to treat both pediatric and adult cases, came on board at UK, he became her pulmonologist. "Some of the therapies we've used have really benefited her," said Dr. Anstead. "We have a lot of patients who need to balance their treatments and their lives. You want them to have a good balance between quantity of life and quality of life."
Multidisciplinary team pays off
"I have a very progressive medical team," said McMahan. "And it's not just the physicians. It's truly a multidisciplinary team." Her team includes a social worker, psychologist, dietitian, respiratory therapist, pharmacist and a nurse coordinator.
"The respiratory therapists have spent hours and hours doing percussive treatments on me," said McMahan. "It's kind of like a ketchup bottle where you turn it upside down and pound on it to make that thick stuff come out."
Due to constant lung infections and other complications, McMahan estimates she has to be admitted to the hospital six weeks out of the year. When that happens, the nursing staff on 3 North always help get her back on her feet. "I have been a patient on that unit over 20 years. Two of the nurses have been my primary nurses for about that long. They know my quirks and preferences and I know theirs," she teased.
New challenges
McMahan's longevity as a patient with CF has come at a cost. She has developed diabetes and osteoporosis, two conditions increasingly common in adult CF patients.
Still, she hasn't let the complications slow her down much. McMahan spends time with her family (she has two boys: one a sophomore in college and one beginning medical school), she plays handbells and continues to work for UK HealthCare as a triage nurse answering the afterhour calls of anxious parents with sick children. Forty years ago, patients afflicted with cystic fibrosis (CF) almost always died in childhood. Thanks to better treatments, many patients today are living well into middle age and encountering two new challenges caused by the disease: diabetes and osteoporosis.
"All patients with cystic fibrosis are more prone to diabetes because secretions get stuck in the pancreas, so the patient doesn't make as much insulin over time," said Dr. Michael
Pulmonologists at UK HealthCare are increasingly ordering genetic tests for their cystic fibrosis (CF) patients, but surprisingly it's not to diagnose the disease. It's to predict what shape the disease will take over the course of a patient's life.
A sweat chloride test is still the easiest way to confirm a patient has CF. "A positive sweat chloride test means you have CF," said Dr. Carolyn Bay, a UK clinical geneticist. "Then we say, well, okay, which mutations? Is it going to be mild CF or severe CF?" At this point, a genetic test is performed.
"A pulmonologist wants to know how best to take care of a person with A Childhood Disease Encounters New Challenges
Genetic Testing: A Crystal Ball for Pulmonologists and CF Patients
Anstead, director of the adult CF Center. It is neither Type 1 nor Type 2 diabetes, but a separate form of the disease.
Osteoporosis develops because CF patients have problems absorbing calcium when they are young, chronic infections prevent them from building up their bones, and CF medicines weaken bones over time. Because of this malabsorption problem, chest percussions, a vital part of CF treatment, become impossible to do when patients have weakened or fractured ribs.
And ominously on the horizon, predicted Dr. Anstead, is cirrhosis of the liver. As in the pancreas, secretions from the liver of CF patients are too thick. The resulting blockages create inflammation and scarring over time, which can lead to cirrhosis.
While CF patients are dealing with more complications the longer they live, these conditions are manageable. The best thing patients have going for them is cooperation, said Dr. Anstead. "There has been a concerted effort of patients, physicians and the Cystic Fibrosis Foundation to make sure patients are getting the best possible care. This cooperation is resulting in better treatments and is a major reason patients are living longer." cystic fibrosis. So we're looking for mutations associated with certain health problems," said Dr. Bay.
Pulmonologist Anstead added another important use for genetic testing in adult CF patients: checking a CF patient's spouse to see if they are a carrier of the CF gene. "If their spouse is a carrier, they have a one in two chance of having a child with CF. If their spouse is not a carrier, then they know their children won't have CF. The children will be carriers of the disease, but that's only an issue if they marry a CF carrier down the road," he said.
